Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$259,277
+$37,361 QoQ
Shares Held
716
+5.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,662
of 3,149 holders
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VICUS CAPITAL holds $5,105,271 across 9 Drug Manufacturers - General names. AMGN ranks #8 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,876 | $1,238,357 | |
| 2 | ABBV |
AbbVie Inc.
|
3,138 | $789,646 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,836 | $749,926 | |
| 4 | LLY |
ELI LILLY & Co
|
584 | $700,467 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,416 | $431,577 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,303 | $363,178 | |
| 7 | NVS |
Novartis AG
|
2,251 | $352,776 | |
| 8 | AMGN |
Amgen Inc
This page
|
716 | $259,277 |
All Filings in AMGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $259,277 | 716 | Shares | Sole | 2026-08-05 | |
| 2025-12-31 | $221,916 | 678 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $201,208 | 713 | Shares | Sole | 2025-10-24 | |
| 2021-03-31 | $361,023 | 1,451 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $306,943 | 1,335 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $295,333 | 1,162 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $201,188 | 853 | Shares | Sole | 2020-08-03 | |
| No filing history on record for this holder in this stock. | ||||||